AG
MDGL icon

AlTi Global’s Madrigal Pharmaceuticals MDGL Stock Holding History

AlTi Global’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$801K Hold
1,492
– – 0.02% 300
2026
Q1 		$781K Sell
1,492
-1
-0.1% -$478 0.02% 264
2025
Q4 		$869K Buy
1,493
+1
+0.1% +$511 0.02% 247
2025
Q3 		$684K Hold
1,492
– – 0.02% 281
2025
Q2 		$452K Hold
1,492
– – 0.01% 312
2025
Q1 		$494K Hold
1,492
– – 0.01% 278
2024
Q4 		$460K Hold
1,492
– – 0.01% 296
2024
Q3 		$317K Hold
1,492
– – 0.01% 316
2024
Q2 		$418K Hold
1,492
– – 0.01% 275
2024
Q1 		$398K Hold
1,492
– – 0.01% 281
2023
Q4 		$345K Buy
+1,492
New +$261K 0.01% 277

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AlTi Global's MDGL Position: Q2 2026 in Review

AlTi Global held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 1,492 shares worth $801K. The position accounts for 0.02% of the portfolio, ranked #300.

AlTi Global first reported a position in MDGL in Q4 2023 and has held it in 11 quarters since. The position peaked at $869K in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • AlTi Global held 1,492 shares of Madrigal Pharmaceuticals worth $801K as of Q2 2026.
  • AlTi Global left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.02% of AlTi Global's portfolio in Q2 2026, its #300 holding.
  • AlTi Global first reported a position in Madrigal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • AlTi Global's Madrigal Pharmaceuticals position peaked at $869K in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on AlTi Global's 13F filing for Q2 2026, filed 5 Aug 2026.